Avon Lifesciences (India) Performance

The firm shows Beta (market volatility) of 0.0 which signifies that the returns on MARKET and Avon Lifesciences are completely uncorrelated. Although it is extremely important to respect Avon Lifesciences historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Avon Lifesciences technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Avon Lifesciences right now shows a risk of 0.0%. Please confirm Avon Lifesciences Coefficient Of Variation, Treynor Ratio as well as the relationship between Treynor Ratio and Semi Variance to decide if Avon Lifesciences will be following its price patterns.

Risk-Adjusted Performance

Over the last 30 days Avon Lifesciences Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Avon Lifesciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Horizon     30 Days    Login   to change

Avon Lifesciences Relative Risk vs. Return Landscape

If you would invest  780.00  in Avon Lifesciences Limited on May 19, 2019 and sell it today you would earn a total of  0.00  from holding Avon Lifesciences Limited or generate 0.0% return on investment over 30 days. Avon Lifesciences Limited is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than Avon Lifesciences and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

Avon Lifesciences Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average Avon Lifesciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avon Lifesciences by adding it to a well-diversified portfolio.

Avon Lifesciences Alerts

Equity Alerts and Improvement Suggestions

Avon Lifesciences is not yet fully synchronised with the market data
Avon Lifesciences has some characteristics of a very speculative penny stock
Avon Lifesciences has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 1.3B in total debt with debt to equity ratio (D/E) of 5.75 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avon Lifesciences has Current Ratio of 0.93 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported revenue of 494.25M. Net Loss for the year was (108.42M) with loss before overhead, payroll, taxes, and interest of (8M).
Check also Trending Equities. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Search macroaxis.com